Drug
100 CI 14c Hmpl 306
100 CI 14c Hmpl 306: highest development phase Phase 1, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| 100 µCi [14C] HMPL-306 NCT06671873 | Phase 1 | Mass Balance Study |
Latest
No recent events.
Follow 100 CI 14c Hmpl 306 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.